New class of cholesterol-lowering study drug may help reduce risk of heart disease but be careful of how the data is presented

Madely Health Headlines Commentary for December 9, 2014

Source:

New drug gives adults cholesterol levels of a baby

Reference:

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial

Bitnami